News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Delaware Court Denies Plaintiffs’ Request to Enjoin CVS Corporation/Caremark Rx Merger
February 26, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NASHVILLE, Tenn.--(BUSINESS WIRE)--Caremark Rx, Inc. (NYSE: CMX) today announced that the Delaware Court of Chancery has denied plaintiffs’ motion to enjoin Caremark’s planned merger with CVS Corporation (NYSE: CVS).
Twitter
LinkedIn
Facebook
Email
Print
Legal
Mergers & acquisitions
Regulatory
MORE ON THIS TOPIC
FDA
UPDATE: Tidmarsh Waffles on Resignation, Will Fight To Clear Name
November 3, 2025
·
3 min read
·
Tristan Manalac
IN PARTNERSHIP WITH ELEMENT
Pharma Faces Investor Woes and Tariff Threats, Turns to AI and Collaboration for Survival
November 3, 2025
·
5 min read
·
BioSpace Insights
Mergers & acquisitions
UPDATE: Pfizer Files Lawsuits Against Novo Nordisk, Metsera To Stop Rival Bid
November 3, 2025
·
4 min read
·
Tristan Manalac
Gene editing
FDA Eyes Accelerated Reviews for Gene Editing Therapies
November 3, 2025
·
2 min read
·
Tristan Manalac
